Profile
| Metric | Value |
|---|---|
| Full Name | LifeStance Health Group, Inc. |
| Ticker | NASDAQ: LFST |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lifestance.com |
| Employees | 7,535 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $7.38 | |
| Price, 1D Change | +1.10% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.66 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +18.50% | |
| EPS | -$0.15 | |
| EPS, 1Y Change | +70.11% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.15 | |
| EPS Estimate | $0.21 | |
| EPS Est. Change | +236.11% | |
| Revenue | $1.25B | |
| Revenue Estimate | $1.42B | |
| Revenue Est. Change | +13.52% | |
| Current Price | $7.38 | |
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +8.40% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.48 | -$0.51 | -5.60% | |
| $0.03 | -$0.15 | -615.31% | |
| $0.21 | N/A | +236.11% | |
| $0.25 | N/A | +264.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.04B | $1.06B | +1.74% | |
| $1.24B | $1.25B | +0.98% | |
| $1.42B | N/A | +13.52% | |
| $1.62B | N/A | +29.80% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -4.16% | |
| Price, 3Y | +48.79% | |
| Market Cap, 1Y | -2.59% | |
| Market Cap, 3Y | +53.95% | |
| Revenue, 1Y | +18.50% | |
| Revenue, 3Y | +87.41% | |
| EPS, 1Y | +70.11% | |
| EPS, 3Y | +85.57% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $7.38 | |
| SMA 200 | $5.70 | |
| SMA 200 vs Price | -22.71% | |
| SMA 50 | $6.45 | |
| SMA 50 vs Price | -12.66% | |
| Beta | 0.66 | |
| ATR | $0.20 | |
| 14-Day RSI | 75.13 | |
| 10-Day Volatility | 20.47% | |
| 1-Year Volatility | 52.22% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.25B | |
| EPS | -$0.15 | |
| Gross Profit | $331.45M | |
| Gross Margin | 26.50% | |
| Operating Profit | -$30.46M | |
| Operating Margin | -2.43% | |
| Net Income | -$57.44M | |
| Net Margin | -4.59% | |
| EBITDA | $40.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.34 | |
| Current Ratio | 1.37 | |
| Quick Ratio | 1.37 | |
| Interest Coverage | - | |
| F-Score | 6 | |
| Altman Z-Score | 2.25 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 2.10 | |
| PB Ratio | 1.92 | |
| EV/EBITDA | 48.74 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.45B | |
| Cash & Equivalents | $154.57M | |
| Total Assets | $2.23B | |
| Current Assets | $312.51M | |
| Total Liabilities | $780.75M | |
| Current Liabilities | $228.89M | |
| Total Debt | $485.19M | |
| Short Term Debt | $56.70M | |
| Accounts Payable | $25.68M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.31B | |
| Operating Expenses | $361.91M | |
| Cost Of Goods Sold | $919.52M | |
| SG&A | $0.00 | |
| D&A | $70.95M | |
| Interest Expense | $0.00 | |
| Income Tax | -$170.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $107.26M | |
| CFI | -$21.57M | |
| CFF | -$9.95M | |
| Capex | $21.57M | |
| Free Cash Flow | $85.69M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| Barclays | ||
| BMO Capital | ||
| UBS | → | |
| BTIG | → | |
| UBS | → | |
| UBS | → | |
| Keybanc | ||
| Canaccord Genuity | ||
| Goldman Sachs | → |
Analyst sentiment
Institutional ownership
Screeners with LFST
Data Sources & References
- LFST Official Website lifestance.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1845257/000119312525269712/0001193125-25-269712-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1845257/000095017025029100/0000950170-25-029100-index.htm
- LFST Profile on Yahoo Finance finance.yahoo.com/quote/LFST
- LFST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lfst
FAQ
What is the ticker symbol for LifeStance Health Group, Inc.?
The ticker symbol for LifeStance Health Group, Inc. is NASDAQ:LFST
Does LifeStance Health Group, Inc. pay dividends?
No, LifeStance Health Group, Inc. does not pay dividends
What sector is LifeStance Health Group, Inc. in?
LifeStance Health Group, Inc. is in the Healthcare sector
What industry is LifeStance Health Group, Inc. in?
LifeStance Health Group, Inc. is in the Medical Care Facilities industry
What country is LifeStance Health Group, Inc. based in?
LifeStance Health Group, Inc. is headquartered in United States
When did LifeStance Health Group, Inc. go public?
LifeStance Health Group, Inc. initial public offering (IPO) was on June 10, 2021
Is LifeStance Health Group, Inc. in the S&P 500?
No, LifeStance Health Group, Inc. is not included in the S&P 500 index
Is LifeStance Health Group, Inc. in the NASDAQ 100?
No, LifeStance Health Group, Inc. is not included in the NASDAQ 100 index
Is LifeStance Health Group, Inc. in the Dow Jones?
No, LifeStance Health Group, Inc. is not included in the Dow Jones index
When was LifeStance Health Group, Inc. last earnings report?
LifeStance Health Group, Inc.'s most recent earnings report was on November 6, 2025
When does LifeStance Health Group, Inc. report earnings?
The next expected earnings date for LifeStance Health Group, Inc. is February 26, 2026
